tyramine has been researched along with Multiple System Atrophy in 1 studies
Multiple System Atrophy: A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92)
| Excerpt | Relevance | Reference |
|---|---|---|
| "There is denervation supersensitivity in PD patients that is, however, insufficient to shift the dose-response curve to the left." | 1.35 | Systemic postganglionic adrenergic studies do not distinguish Parkinson's disease from multiple system atrophy. ( Lipp, A; Low, PA; Sandroni, P, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lipp, A | 1 |
| Sandroni, P | 1 |
| Low, PA | 1 |
1 other study available for tyramine and Multiple System Atrophy
| Article | Year |
|---|---|
Systemic postganglionic adrenergic studies do not distinguish Parkinson's disease from multiple system atrophy.
Topics: Adrenergic Agonists; Aged; Analysis of Variance; Baroreflex; Blood Pressure; Cohort Studies; Diagnos | 2009 |